Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer

The incidence of high-risk Human Papillomavirus (HR-HPV)-driven head and neck squamous cell carcinoma (HNSCC) is on the rise globally. HR-HPV-driven HNSCC displays molecular and clinical characteristics distinct from HPV-uninvolved cases. Therapeutic strategies for HR-HPV-driven HNSCC are under inve...

Full description

Bibliographic Details
Main Authors: Qiang Xu, Ye Chen, Yuan Jin, Zhiyu Wang, Haoru Dong, Andreas M. Kaufmann, Andreas E. Albers, Xu Qian
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Viruses
Subjects:
HPV-related cancer
oropharyngeal cancer
cancer vaccine
nanotechnology
immunotherapy
photoimmunotherapy
Online Access:https://www.mdpi.com/1999-4915/14/12/2824

Internet

https://www.mdpi.com/1999-4915/14/12/2824

Similar Items